Alaunos Therapeutics, Inc.·4

Dec 1, 4:05 PM ET

Postma Robert W 4

4 · Alaunos Therapeutics, Inc. · Filed Dec 1, 2022

Insider Transaction Report

Form 4
Period: 2022-11-29
Transactions
  • Purchase

    Common Stock

    2022-11-29$0.65/sh+750,000$487,5005,000,000 total(indirect: By WaterMill Asset Management Corp.)
Holdings
  • Common Stock

    (indirect: By Spouse)
    3,574
  • Common Stock

    1,241,870
Footnotes (3)
  • [F1]The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp.
  • [F2]The shares were purchased in a registered underwritten offering on November 29, 2022.
  • [F3]Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION